• sales@syndicatedanalytics.com
  • +1-213-316-7435

Postmenopausal Vaginal Atrophy Drugs Market: Global Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth and Forecast, 2021-2026



“Postmenopausal Vaginal Atrophy Drugs Market: Global Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth and Forecast, 2021-2026” provides a deep and thorough evaluation of the Postmenopausal vaginal atrophy drugs market by drug form (vaginal gels, creams, tablets, rings, and patches); by therapy type (estrogen-based drugs, non-estrogen-based drugs ); and by geography (North America, Europe, Asia-Pacific, Latin America and Middle East & Africa). Postmenopausal vaginal atrophy refers to the deterioration of vaginal tissues caused due to the low levels of estrogen production in the body after menopause. Some of the common symptoms include dryness, irritation, itching, dyspareunia, and vaginal discharge. It can be treated using various specific drug therapies, including estrogen- and non-estrogen-based therapies.

The global market is driven by the growing awareness among the masses regarding the available drugs and treatment solutions for postmenopausal vaginal atrophy. Furthermore, non-estrogenic therapies are gaining widespread preference over systemic estrogen treatments, thereby creating a positive outlook for the market. The continual improvements in the delivery of medical facilities and the rising healthcare expenditure are some of the other factors contributing to the market growth.  

Segmentation by Drug Form:   

  • Vaginal Gels
  • Creams
  • Tablets
  • Rings
  • Patches

Segmentation by Therapy Type:

  • Estrogen-Based Drugs
  • Non-Estrogen-Based Drugs

Segmentation by Region:

  • Asia-Pacific
  • Europe
  • Latin America
  • North America
  • Middle East & Africa

Competitive Landscape:

  • Teva Pharmaceuticals
  • Shionogi
  • Pfizer
  • Novo Nordisk
  • Allergan

The price margins for the products along with the various success and risk factors for manufacturers have also been covered in the report. Moreover, in order to determine market attractiveness, the report analyses the Postmenopausal vaginal atrophy drugs industry along the parameters of the porter’s five forces model. This model examines the degree of competition in the Postmenopausal vaginal atrophy drugs industry by analysing the threat posed by new entrants and substitutes, and the bargaining power of suppliers and buyers. Swot analysis of the market has also been presented in the report which highlights the strengths, weaknesses, opportunities and threats pertaining to the Postmenopausal vaginal atrophy drugs industry. Furthermore, the value chain analysis of the Postmenopausal vaginal atrophy drugs industry has also been covered in the report. This comprises of all the activities in the value chain, such as the procurement of various raw materials, manufacturing and sales of the products, and their distribution.

Highlights of The Postmenopausal Vaginal Atrophy Drugs Market

  • Historical and current scenario
  • Trends and developments
  • Market forecast
  • Price analysis and forecast
  • Porter’s five forces analysis
  • SWOT analysis
  • Value chain analysis

The report is a result of exhaustive primary and secondary research undertaken by analysts having years of experience in the Postmenopausal vaginal atrophy drugs industry. All the qualitative and quantitative aspects of the industry have been covered and the collected data has been analysed and presented in the form of easily comprehensible charts, graphs and tables.

1 Introduction 
    1.1 Research Objectives 
    1.2 Stakeholders
    1.3 Scope of the Report
    1.4 Assumptions and Limitations
2. Research Methodology 
    2.1. Data Collection
       2.1.1 Primary Sources
       2.1.2 Secondary Sources
    2.2 Market Size Estimation
        2.2.1 Bottom-Up Approach
        2.2.2 Top-Down Approach
    2.3 Data Validation
3. Executive Summary
4. Global Post Menopausal Vaginal Atrophy Drugs Market

     4.1 Industry Overview
     4.2 Key Industry Developments
     4.3 Market Trends
        4.3.1 Key Market Indicators
        4.3.2 Historical Market Trends
        4.3.3 Market Forecast
     4.4 Price Analysis
        4.4.1 Key Price Indicators
        4.4.2 Pricing Structure
        4.4.3 Historical Price Trends
        4.4.4 Price Forecast
     4.5 Market Breakup By Region
     4.6 Market Breakup By Drug Form
     4.7 Market Breakup By Therapy Type
5. Global Post Menopausal Vaginal Atrophy Drugs Market: Value Chain Analysis
     5.1 Overview
     5.2 Research and Development
     5.3 Raw Material Suppliers
     5.4 Inbound Logistics
     5.5 Production
     5.6 Marketing 
     5.7 Outbound Logistics
     5.8 Consumers
6. Global Post Menopausal Vaginal Atrophy Drugs Market: SWOT Analysis
     6.1 Overview
     6.2 Strengths
     6.3 Weaknesses
     6.4 Opportunities
     6.5 Threats
7. Global Post Menopausal Vaginal Atrophy Drugs Market: Porter’s Five Forces Analysis
     7.1 Overview
     7.2 Threat of New Entrants
     7.3 Threat of Substitutes
     7.4 Bargaining Power of Buyers
     7.5 Bargaining Power of Suppliers
     7.6 Intensity of Rivalry
8.  Competitive Landscape
     8.1 Market Structure
     8.2 Key Players 
     8.3 Key Success Factors 
9. Performance By Region
     9.1 North America
         9.1.1 Overview
         9.1.2 Market Trends
         9.1.3 Market Segmentation
         9.1.4 Market Forecast
     9.2 Europe
         9.2.1 Overview
         9.2.2 Market Trends
         9.2.3 Market Segmentation
         9.2.4 Market Forecast
     9.3 Asia Pacific 
        9.3.1 Overview
        9.3.2 Market Trends
        9.3.3 Market Segmentation
        9.3.4 Market Forecast
     9.4 Latin America
        9.4.1 Overview
        9.4.2 Market Trends
        9.4.3 Market Segmentation
        9.4.4 Market Forecast
     9.5 Middle East and Africa
        9.5.1 Overview
       9.5.2 Market Trends
       9.5.3 Market Segmentation
       9.5.4 Market Forecast
10 Key Player Profiles

List of Figures

    

Figure 1: Global: Postmenopausal Vaginal Atrophy Drugs Market, 2015 - 2020
Figure 2: Global: Postmenopausal Vaginal Atrophy Drugs Market Forecast, 2021 - 2026
Figure 3: Global: Postmenopausal Vaginal Atrophy Drugs Market: Price Trends, 2015 - 2020
Figure 4: Global: Postmenopausal Vaginal Atrophy Drugs Market Forecast: Price Trends, 2021 - 2026
Figure 5: Global: Postmenopausal Vaginal Atrophy Drugs Market: Breakup by Region, 2020
Figure 6: Global: Postmenopausal Vaginal Atrophy Drugs Market: Breakup by Type, 2020
Figure 7: Global: Postmenopausal Vaginal Atrophy Drugs Market: Breakup by End Use, 2020
Figure 8: Global: Postmenopausal Vaginal Atrophy Drugs Industry: Value Chain Analysis
Figure 9: Global: Postmenopausal Vaginal Atrophy Drugs Industry: SWOT Analysis
Figure 10: Global: Postmenopausal Vaginal Atrophy Drugs Industry: Porter’s Five Forces Analysis
Figure 11: Global: Postmenopausal Vaginal Atrophy Drugs Market: Key Players
Figure 12: North America: Postmenopausal Vaginal Atrophy Drugs Market, 2015-2020
Figure 13: North America: Postmenopausal Vaginal Atrophy Drugs Market: Breakup by Segment, 2020
Figure 14: North America: Postmenopausal Vaginal Atrophy Drugs Market Forecast, 2021-2026
Figure 15: Europe: Postmenopausal Vaginal Atrophy Drugs Market, 2015-2020
Figure 16: Europe: Postmenopausal Vaginal Atrophy Drugs Market: Breakup by Segment, 2020
Figure 17: Europe: Postmenopausal Vaginal Atrophy Drugs Market Forecast, 2021-2026
Figure 18: Asia Pacific: Postmenopausal Vaginal Atrophy Drugs Market, 2015-2020
Figure 19: Asia Pacific: Postmenopausal Vaginal Atrophy Drugs Market: Breakup by Segment, 2020
Figure 20: Asia Pacific: Postmenopausal Vaginal Atrophy Drugs Market Forecast, 2021-2026
Figure 21: Latin America: Postmenopausal Vaginal Atrophy Drugs Market, 2015-2020
Figure 22: Latin America: Postmenopausal Vaginal Atrophy Drugs Market: Breakup by Segment, 2020
Figure 23: Latin America: Postmenopausal Vaginal Atrophy Drugs Market Forecast, 2021-2026
Figure 24: Middle East and Africa: Postmenopausal Vaginal Atrophy Drugs Market, 2015-2020
Figure 25: Middle East and Africa: Postmenopausal Vaginal Atrophy Drugs Market: Breakup by Segment, 2020
Figure 26: Middle East and Africa: Postmenopausal Vaginal Atrophy Drugs Market Forecast, 2021-2026
 


List of Tables

Table 1: Global: Postmenopausal Vaginal Atrophy Drugs Industry: Market Summary    
Table 2: Global: Postmenopausal Vaginal Atrophy Drugs Industry: Market Overview, 2020 and 2026
Table 3: Global: Postmenopausal Vaginal Atrophy Drugs Industry: Market Structure    
Table 4: Global: Postmenopausal Vaginal Atrophy Drugs Market: Market by Region, 2020-2026    
 

Special Prices


    Syndicated Analytics provides special pricing for:

  • Academic Institutes
  • Government Agencies
  • Nonprofit Organizations

  • For more information, feel free to contact us.





Related Reports

Baby Oil Manufacturing Plant Project Report: Industry Trends, Manufacturing Process, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue 2021-2026

The baby oil manufacturing plant project report offers an in-depth roadmap or setting up a baby oil manufacturing plant covering the essential techno-commercial aspects.

Sanitary Napkins Manufacturing Plant Project Report: Industry Trends, Manufacturing Process, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue 2021-2026

The report offers an in-depth roadmap or setting up a sanitary napkins manufacturing plant covering the essential techno-commercial aspects.

Surgical Gloves Manufacturing Plant Project Report: Industry Trends, Manufacturing Process, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue 2021-2026

The report offers an in-depth roadmap or setting up a surgical gloves manufacturing plant covering the essential techno-commercial aspects.

GCC Healthcare Information Software Market by Development (On-Premise and Cloud) and Application (Hospitals, Clinics, Medical Research Centers and others):Industry Analysis, Trends, Growth and Forecast 2020-2025

The GCC Healthcare Information Software Market was worth US$ XX Billion in 2019, expanding at a CAGR of X% during 2012-2019. The market is projected to register a CAGR of X% during 2020-2025, reaching US$ XX Billion by 2025.